Skip to main content

Table 2 Anticancer activity of Pep27 and of its analogues in various cancer cell lines by MTT assay

From: Functional and structural characteristics of anticancer peptide Pep27 analogues

Peptide

IC50 (μM)

 

AML-2

HL-60

Jurkat

SNU-601

MCF-7

Pep27

>70

>70

>70

>70

>70

Pep27anal1

50

53

47

37

55

Pep27anal2

29

20

23

25

<10

Pep27anal3

67

52

50

50

38

Pep27anal4

50

51

46

37

29

Pep27anal5

>70

>70

>70

>70

>70

  1. AML-2, acute myelogenous leukemia cell line; HL-60, acute promyelocytic leukemia cell line; Jurkat, T cell leukemia cell line; SNU-601, gastric cancer cell line; MCF-7, breast cancer cell line